BanwellBGhezziABar-OrA. Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol2007; 6: 887–902.
2.
GhezziABanwellBBoykoA. The management of multiple sclerosis in children: A European view. Mult Scler2010; 16: 1258–1267.
3.
McKeonALennonVALotzeT. CNS aquaporin-4 autoimmunity in children. Neurology2008; 71: 93–100.
4.
AbsintaMRoccaMAMoiolaL. Cortical lesions in children with multiple sclerosis. Neurology2011; 76: 910–913.
5.
SchoderboeckLAdzemovicMNicolussiEM. The ‘window of susceptibility’ for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines. Neurobiol Dis2009; 35: 368–375.
6.
BanwellBBar-OrAArnoldDL. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol2011; 10: 436–445.
7.
DisantoGMagalhaesSHandelAE. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology2011; 76: 781–786.
8.
MikaeloffYCaridadeGTardieuM. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain2007; 130: 2589–2595.
9.
Langer-GouldABraraSMBeaberBE. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology2013; 80: 548–552.
10.
KetelslegersIACatsman-BerrevoetsCENeuteboomRF. Incidence of acquired demyelinating syndromes of the CNS in Dutch children: A nationwide study. J Neurol2012; 259: 1929–1935.
